5/5 Dedi L. 1 year ago on Google β’ 27 reviews
102.
SYRUP
MEDICINE
IS
WITHDRAWN.
WHO
IS
RESPONSIBLE...
THE
PRODUCER
LICENSE
IS
KEMENKESKAH..
THE
MEDICINE
WAS
NOT
BEFORE.
THERE
WAS
RULES
FOR
THE
MEDICINE
IN
CIRCULATION.
WHERE
THE
BPPOM
HAD
TO
TEST.
WHETHER
THE
CHILDREN'S
SYRUP
MEDICINE
WAS
FIT
FOR
CONSUMPTION
OR
UNHEALTHY
OR
NOT...
ADEQUATE
OR
NOT
WHETHER
IT
IS
DANGEROUS
OR
NOT.
WHETHER
THE
POM
IS
VERY
RESPONSIBLE
FOR
THE
CIRCULATION
OF
CHILDREN'S
MEDICINE
WHICH
ARE
CURRENTLY
WITHDRAWAL,
WHETHER
THERE
ARE
POLITICAL
ELEMENTS
THERE
ARE
THE
HEARTS
OF
THOSE
WHO
ISSUED
THE
PERMIT
DO
NOT
GET
A
PORTION
OF
THE
STRATEGIC
POSITION
OR
THERE
ARE
THINGS
THAT
THE
LAYOUT
COMMUNITY
DOESN'T
KNOW.
THE
MANUFACTURER'S
CIRCULATION
IS
A
CONCERNED
PREROGATIVE
RIGHT...
SO
THAT
THOSE
WHO
ISSUED
A
PERMIT
NEED
TO
BE
TRIED
BY
ANYONE.
THOSE
WHO
ISSUED
A
PERMIT
MUST
BE
TRIED.
AND
AS
THE
INDONESIAN
COMMUNITY
THEY
HAVE
THE
RIGHT
TO
RECEIVE
ROYALTY.
Ministry
of
Health
Announces
List
of
102
Syrup
Medicines
Prohibited
from
Distribution
KHAJJAR
ROHMAH
24
OCTOBER
2022
9:45AM
HEALTH
13361
TIMES
VIEWED
JakartaΒ -
The
Ministry
of
Health
(Kemenkes)
of
the
Republic
of
Indonesia
announced
that
102
syrup
drugs
are
prohibited
from
circulating
and
being
consumed
by
the
public.
The
announcement
follows
the
Ministry
of
Health's
findings
regarding
cases
of
Atypical
Progressive
Acute
Kidney
Disorders
(GGAPA)
in
children.
"Don't
prescribe
these
102
medicines
yet,
the
list
of
102
is
still
conservative
and
narrower
than
all
syrup
medicines,"
said
Minister
of
Health
Budi
Gunadi
Sadikin
accompanied
by
Director
General
of
Pharmaceuticals
and
Medical
Devices
Lucia
Rizka
Andalusiaz
when
giving
a
press
statement
at
the
Ministry
of
Health
Office,
Jakarta,
Friday
(21
/10/2022).
οΏΌ
According
to
the
Ministry
of
Health's
findings,
102
syrup
drugs
are
suspected
to
be
the
cause
of
acute
kidney
problems
in
children.
This
discovery
was
the
result
of
an
investigation
by
the
Ministry
of
Health
into
a
sampling
of
medicines
found
in
the
residences
and
hospitals
of
child
patients
who
experienced
ADD.
Apart
from
being
a
precautionary
measure,
this
announcement
was
also
made
to
lift
the
ban
on
the
consumption
of
all
syrup
medicines.
Precisely
at
the
pharmacy
and
prescribed
by
a
doctor
based
on
the
circular
letter
(SE)
of
the
Ministry
of
Health
Number
SR.01.05/III/3461/2022.
Thus,
the
consumption
ban
only
applies
to
102
drugs
suspected
of
containing
excessive
contamination.
Namely,
contamination
of
ethylene
glycol,
diethylene
glycol,
and
ethylene
glycol
butyl
ether
or
EGBE.
These
three
chemical
compounds
are
the
cause
of
death
from
acute
kidney
disease
in
children
that
occurred
in
Gambia,
West
Africa.
Furthermore,
these
102
syrup
drugs
which
are
prohibited
from
distribution
are
still
being
investigated
further
by
the
Food
and
Drug
Supervisory
Agency
(BPOM).
Previously,
BPOM
had
withdrawn
distribution
permits
for
five
syrup
medicinal
products
containing
ethylene
glycol
and
diethylene
glycol
(DEG)
that
exceeded
the
limit.
Among
others
are:
Termorex
Syrup
(fever
medicine),
produced
by
PT
Konimex
with
distribution
permit
number
DBL7813003537A1,
box
packaging,
plastic
bottle
@
60
ml.
Flurin
DMP
Syrup
(cough
and
flu
medicine),
produced
by
PT
Yarindo
Farmatama
with
distribution
permit
number
DTL0332708637A1,
box
packaging,
plastic
bottle
@
60
ml.
Unibebi
Cough
Syrup
(cough
and
flu
medicine),
produced
by
Universal
Pharmaceutical
Industries
with
distribution
permit
number
DTL7226303037A1,
box
packaging,
plastic
bottle
@
60
ml.
Unibebi
Fever
Syrup
(fever
medicine),
produced
by
Universal
Pharmaceutical
Industries
with
distribution
permit
number
DBL8726301237A1,
box
packaging,
bottle
@
60
ml.
And
Unibebi
Fever
Drops
(fever
medicine),
produced
by
Universal
Pharmaceutical
Industries
with
distribution
permit
number
DBL1926303336A1,
box
packaging,
bottle
@
15
ml.
Meanwhile,
the
complete
list
of
102
dangerous
syrup
drugs
that
are
prohibited
for
consumption,
sold
by
pharmacies
and
prescribed
by
doctors
is
as
follows:
(see
picture)
